Bioxcel Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $448k | 152k | 2.95 |
| 2023-09-30 | $391k | 155k | 2.53 |
| 2023-06-30 | $1.3M | 200k | 6.66 |
| 2023-03-31 | $2.6M | 140k | 18.66 |
| 2022-12-31 | $3.5M | 163k | 21.48 |
| 2022-06-30 | $2.5M | 186k | 13.22 |
| 2022-03-31 | $3.5M | 166k | 20.90 |
| 2021-12-31 | $4.5M | 220k | 20.41 |
| 2021-09-30 | $5.1M | 168k | 30.35 |
| 2021-06-30 | $6.0M | 205k | 29.06 |
| 2021-03-31 | $7.4M | 172k | 43.17 |
| 2020-12-31 | $43M | 935k | 46.20 |
| 2020-09-30 | $36M | 829k | 43.36 |
| 2020-06-30 | $21M | 386k | 53.01 |
| 2020-03-31 | $822k | 37k | 22.34 |